Advertisement
Person › Details
Andreas Bergmann (SphingoTec GmbH)
Bergmann, Andreas (Sphingotec GmbH 201301 Managing Director)
Organisation | SphingoTec GmbH | |
Group | SphingoTec (Group) | |
Product | cancer test, early detection | |
Record changed: 2021-11-29 |
Advertisement
More documents for Andreas Bergmann
- [1] SphingoTec GmbH. (11/29/21). "Press Release: SphingoTec Appoints Jörg Menten to Leadership Team as Chief Commercial Officer to Drive New Business Growth". Hennigsdorf....
- [2] Adrenomed AG. (11/30/20). "Press Release: Adrenomed Closes EUR 22 Million Equity Financing to Accelerate Development of Adrecizumab (HAM8101) and Provides Business Update". Hennigsdorf....
- [3] Sphingotec GmbH. (4/16/20). "Press Release: SphingoTec Expands Leadership Team and Appoints Achim Plum as Managing Director and Chief Commercial Officer". Hennigsdorf....
- [4] Adrenomed AG. (2/21/20). "Press Release: Adrenomed Announces Positive Top-Line AdrenOSS-2 Phase II Results with Adrecizumab in Septic Shock". Hennigsdorf....
- [5] SphingoTec GmbH. (12/16/19). "Press Release: SphingoTec’s Proprietary Biomarker bio-ADM Detects Residual Congestion in Patients with Heart Failure". Hennigsdorf....
- [6] 4Teen4 Pharmaceuticals GmbH. (12/5/19). "Press Release: Biotech Startup 4Teen4 Pharmaceuticals Closes EUR 7 Million Series A Financing". Hennigsdorf....
- [7] Adrenomed AG. (9/26/19). "Press Release: Adrenomed Completes Full Enrollment with 300 Patients in AdrenOSS-2 Trial with Adrecizumab in Septic Shock". Hennigsdorf....
- [8] SphingoTec GmbH. (10/8/18). "Press Release: SphingoTec Raises €20 Million from HBM and Wellington Partners". Hennigsdorf....
- [9] SphingoTec GmbH. (5/22/18). "Press Release: SphingoTec Is Adding an Advanced POC Testing Platform to Portfolio". Hennigsdorf & San Diego, CA....
- [10] Adrenomed AG. (12/11/17). "Press Release: Adrenomed AG Doses First Patient in Proof of Concept Study with Adrecizumab to Treat Patients with Early Septic Shock". Hennigsdorf....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top